Global Pharmaceutical Analytical Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256528

Publication Date:

March 3, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Pharmaceutical Analytical Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Pharmaceutical Analytical Service refers to the scientific testing and analysis of pharmaceutical products to ensure their quality, safety, and efficacy. It involves various analytical techniques and methods to evaluate the chemical composition, physical properties, and performance of pharmaceutical drugs and related materials.
Pharmaceutical analytical services are typically provided by specialized laboratories or companies that have expertise in pharmaceutical analysis. These services are crucial in the development, manufacturing, and quality control of pharmaceutical products. They help pharmaceutical companies to comply with regulatory requirements, such as those set by the Food and Drug Administration (FDA) in the United States.
Some common pharmaceutical analytical services include:
1. Method development and validation: Developing and validating analytical methods to accurately measure the concentration and purity of active pharmaceutical ingredients (APIs) and other components in a drug formulation.
2. Stability testing: Assessing the stability of pharmaceutical products under various storage conditions to determine their shelf life and ensure that they remain safe and effective throughout their intended use.
3. Impurity analysis: Identifying and quantifying impurities or degradation products in pharmaceutical products, which may arise during manufacturing, storage, or use.
4. Dissolution testing: Evaluating the rate at which a drug substance dissolves in a specified medium, which is important for determining its bioavailability and ensuring consistent drug release.
5. Particle size analysis: Measuring the size distribution of particles in pharmaceutical formulations, as it can affect the drug"s performance, stability, and bioavailability.
6. Microbiological testing: Assessing the microbial contamination of pharmaceutical products to ensure they meet the required standards for sterility and safety.
7. Elemental analysis: Determining the elemental composition of pharmaceutical materials, such as metals or trace elements, which can impact product quality and safety.
8. Bioanalytical testing: Analyzing biological samples, such as blood or urine, to measure drug concentrations or assess the pharmacokinetics and pharmacodynamics of a drug.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淧harmaceutical Analytical Service Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Analytical Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Analytical Service sales for 2025 through 2031. With Pharmaceutical Analytical Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Analytical Service industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Analytical Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Analytical Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Analytical Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Analytical Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Analytical Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Analytical Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chromatographic Techniques
Spectroscopic Techniques
Other
Segmentation by Application:
Enterprise
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alfa Chemistry
Intertek
Lonza
Solvias
Aurigene Pharmaceutical Services
Vetter
NUVISAN
BCM Analytical Services
Callidus Research Laboratories
BRS Analytical Services
Cambridge Pharma
API
Lifecore Biomedical
Glatt
Vectura
Symbiosis Pharmaceutical Services
Conscio Pharmaceuticals

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical Analytical Service 麻豆原创 Size (2020-2031)
2.1.2 Pharmaceutical Analytical Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Analytical Service by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Analytical Service Segment by Type
2.2.1 Chromatographic Techniques
2.2.2 Spectroscopic Techniques
2.2.3 Other
2.3 Pharmaceutical Analytical Service 麻豆原创 Size by Type
2.3.1 Pharmaceutical Analytical Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Analytical Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pharmaceutical Analytical Service Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Pharmaceutical Analytical Service 麻豆原创 Size by Application
2.5.1 Pharmaceutical Analytical Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Analytical Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pharmaceutical Analytical Service 麻豆原创 Size by Player
3.1 Pharmaceutical Analytical Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical Analytical Service Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Analytical Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pharmaceutical Analytical Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Analytical Service by Region
4.1 Pharmaceutical Analytical Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Pharmaceutical Analytical Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Analytical Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pharmaceutical Analytical Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pharmaceutical Analytical Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Analytical Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Analytical Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pharmaceutical Analytical Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pharmaceutical Analytical Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Analytical Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pharmaceutical Analytical Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pharmaceutical Analytical Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Analytical Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pharmaceutical Analytical Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pharmaceutical Analytical Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Analytical Service by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Analytical Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Analytical Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Analytical Service 麻豆原创 Forecast
10.1 Global Pharmaceutical Analytical Service Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Analytical Service Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Analytical Service Forecast
10.1.3 APAC Pharmaceutical Analytical Service Forecast
10.1.4 Europe Pharmaceutical Analytical Service Forecast
10.1.5 Middle East & Africa Pharmaceutical Analytical Service Forecast
10.2 Americas Pharmaceutical Analytical Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pharmaceutical Analytical Service Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical Analytical Service Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical Analytical Service Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical Analytical Service Forecast
10.3 APAC Pharmaceutical Analytical Service Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Analytical Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical Analytical Service Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical Analytical Service Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical Analytical Service Forecast
10.3.5 India 麻豆原创 Pharmaceutical Analytical Service Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical Analytical Service Forecast
10.4 Europe Pharmaceutical Analytical Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pharmaceutical Analytical Service Forecast
10.4.2 France 麻豆原创 Pharmaceutical Analytical Service Forecast
10.4.3 UK 麻豆原创 Pharmaceutical Analytical Service Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical Analytical Service Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical Analytical Service Forecast
10.5 Middle East & Africa Pharmaceutical Analytical Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pharmaceutical Analytical Service Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical Analytical Service Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical Analytical Service Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical Analytical Service Forecast
10.6 Global Pharmaceutical Analytical Service Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Analytical Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical Analytical Service Forecast
11 Key Players Analysis
11.1 Alfa Chemistry
11.1.1 Alfa Chemistry Company Information
11.1.2 Alfa Chemistry Pharmaceutical Analytical Service Product Offered
11.1.3 Alfa Chemistry Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Alfa Chemistry Main Business Overview
11.1.5 Alfa Chemistry Latest Developments
11.2 Intertek
11.2.1 Intertek Company Information
11.2.2 Intertek Pharmaceutical Analytical Service Product Offered
11.2.3 Intertek Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Intertek Main Business Overview
11.2.5 Intertek Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Pharmaceutical Analytical Service Product Offered
11.3.3 Lonza Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Solvias
11.4.1 Solvias Company Information
11.4.2 Solvias Pharmaceutical Analytical Service Product Offered
11.4.3 Solvias Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Solvias Main Business Overview
11.4.5 Solvias Latest Developments
11.5 Aurigene Pharmaceutical Services
11.5.1 Aurigene Pharmaceutical Services Company Information
11.5.2 Aurigene Pharmaceutical Services Pharmaceutical Analytical Service Product Offered
11.5.3 Aurigene Pharmaceutical Services Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Aurigene Pharmaceutical Services Main Business Overview
11.5.5 Aurigene Pharmaceutical Services Latest Developments
11.6 Vetter
11.6.1 Vetter Company Information
11.6.2 Vetter Pharmaceutical Analytical Service Product Offered
11.6.3 Vetter Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Vetter Main Business Overview
11.6.5 Vetter Latest Developments
11.7 NUVISAN
11.7.1 NUVISAN Company Information
11.7.2 NUVISAN Pharmaceutical Analytical Service Product Offered
11.7.3 NUVISAN Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 NUVISAN Main Business Overview
11.7.5 NUVISAN Latest Developments
11.8 BCM Analytical Services
11.8.1 BCM Analytical Services Company Information
11.8.2 BCM Analytical Services Pharmaceutical Analytical Service Product Offered
11.8.3 BCM Analytical Services Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 BCM Analytical Services Main Business Overview
11.8.5 BCM Analytical Services Latest Developments
11.9 Callidus Research Laboratories
11.9.1 Callidus Research Laboratories Company Information
11.9.2 Callidus Research Laboratories Pharmaceutical Analytical Service Product Offered
11.9.3 Callidus Research Laboratories Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Callidus Research Laboratories Main Business Overview
11.9.5 Callidus Research Laboratories Latest Developments
11.10 BRS Analytical Services
11.10.1 BRS Analytical Services Company Information
11.10.2 BRS Analytical Services Pharmaceutical Analytical Service Product Offered
11.10.3 BRS Analytical Services Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 BRS Analytical Services Main Business Overview
11.10.5 BRS Analytical Services Latest Developments
11.11 Cambridge Pharma
11.11.1 Cambridge Pharma Company Information
11.11.2 Cambridge Pharma Pharmaceutical Analytical Service Product Offered
11.11.3 Cambridge Pharma Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Cambridge Pharma Main Business Overview
11.11.5 Cambridge Pharma Latest Developments
11.12 API
11.12.1 API Company Information
11.12.2 API Pharmaceutical Analytical Service Product Offered
11.12.3 API Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 API Main Business Overview
11.12.5 API Latest Developments
11.13 Lifecore Biomedical
11.13.1 Lifecore Biomedical Company Information
11.13.2 Lifecore Biomedical Pharmaceutical Analytical Service Product Offered
11.13.3 Lifecore Biomedical Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Lifecore Biomedical Main Business Overview
11.13.5 Lifecore Biomedical Latest Developments
11.14 Glatt
11.14.1 Glatt Company Information
11.14.2 Glatt Pharmaceutical Analytical Service Product Offered
11.14.3 Glatt Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Glatt Main Business Overview
11.14.5 Glatt Latest Developments
11.15 Vectura
11.15.1 Vectura Company Information
11.15.2 Vectura Pharmaceutical Analytical Service Product Offered
11.15.3 Vectura Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Vectura Main Business Overview
11.15.5 Vectura Latest Developments
11.16 Symbiosis Pharmaceutical Services
11.16.1 Symbiosis Pharmaceutical Services Company Information
11.16.2 Symbiosis Pharmaceutical Services Pharmaceutical Analytical Service Product Offered
11.16.3 Symbiosis Pharmaceutical Services Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Symbiosis Pharmaceutical Services Main Business Overview
11.16.5 Symbiosis Pharmaceutical Services Latest Developments
11.17 Conscio Pharmaceuticals
11.17.1 Conscio Pharmaceuticals Company Information
11.17.2 Conscio Pharmaceuticals Pharmaceutical Analytical Service Product Offered
11.17.3 Conscio Pharmaceuticals Pharmaceutical Analytical Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Conscio Pharmaceuticals Main Business Overview
11.17.5 Conscio Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.